Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

451
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

410
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
410
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

267
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
267
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

245
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
245
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

565
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
565
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

381
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyp Detection Using YOLOv9 on Real and Synthetic Colonoscopy Images.

Journal of gastroenterology and hepatology·2026
Same author

High detection rates and associated factors of colorectal serrated lesions: a multicenter prospective study in the Asia-Pacific.

The American journal of gastroenterology·2026
Same author

Second Asian Consensus Report on Functional Dyspepsia (2025): Updated Recommendations.

Journal of gastroenterology and hepatology·2026
Same author

Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence.

Cancer discovery·2026
Same author

Embracing minimally invasive approaches to colorectal cancer resection.

Singapore medical journal·2025
Same author

Welcome to the Teal Journal: A New Look, A Greater Vision.

Journal of gastroenterology and hepatology·2025

Related Experiment Video

Updated: Oct 12, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards.

Shu Wen Tay1, Kevin Kim Jun Teh1, Tiing-Leong Ang1,2,3

  • 1Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore.

Singapore Medical Journal
|November 26, 2021
PubMed
Summary

Ulcerative colitis treatments have advanced, focusing on disease control for better outcomes and reduced colorectal cancer risk. New therapies target inflammation, aiming for endoscopic and histological healing.

More Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

423
Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.5K

Related Experiment Videos

Last Updated: Oct 12, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

423
Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.5K

Area of Science:

  • Gastroenterology and Inflammatory Bowel Disease Research

Background:

  • The management of ulcerative colitis (UC) has significantly evolved over the past 20 years.
  • Pharmacotherapeutic advancements have introduced novel treatment options, with numerous agents currently under development.
  • Increased understanding of inflammatory pathways has enabled targeted drug therapies, leading to improved clinical outcomes through enhanced disease control.

Purpose of the Study:

  • To review the advancements in ulcerative colitis treatment over the last two decades.
  • To highlight the shift in treatment goals towards achieving endoscopic and histological healing.
  • To emphasize the importance of disease activity control in mitigating colorectal cancer risk.

Main Methods:

  • Review of recent literature on ulcerative colitis pharmacotherapeutics and treatment strategies.
  • Analysis of the impact of new treatment targets on patient outcomes.
  • Evaluation of updated colorectal cancer screening guidelines in the context of inflammatory bowel disease.

Main Results:

  • Significant progress in pharmacotherapeutics has led to new treatment options for ulcerative colitis.
  • A paradigm shift in treatment targets from symptom management to achieving endoscopic and histological remission.
  • Effective disease control in ulcerative colitis is associated with a reduced risk of colorectal cancer development.

Conclusions:

  • Modern ulcerative colitis management prioritizes achieving deeper remission, including endoscopic and histological healing.
  • Controlling disease activity is crucial for improving patient outcomes and preventing complications like colorectal cancer.
  • Enhanced diagnostic tools, such as dye-based chromoendoscopy and high-definition colonoscopy, are vital for accurate colorectal cancer screening in UC patients.